5Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries[J]. J Clin Epidemiol, 1993, 46: 1323-1330.
6Evans DC, Watt AP, Nicoll-Grittith DA, et al. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development[J]. Chem Res Toxicol, 2004, 17: 3-16.
7Chalasani N, Fontana RJ,Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States[J]. Gastroenterology, 2008, 135: 1924-1936.
8Norris W, Paredes AH, Lewis JH. Drug-induced liver injury in 2007[J]. Curt Opin Gastroenterol, 2008, 24: 287-297.
